Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3226 AdvaMed’s annual conference and exhibition travelled across the country to San Diego in 2015, its first time on the West Coast. This year’s conference represented a spectacular celebration of AdvaMed’s 40th anniversary, with an audience of over 2,300 attendees representing over 900 companies and stakeholder groups from 26 countries. The conference also featured its largest- ever exhibit hall, with more than 140 exhibitors displaying their latest products and services, demonstrating once again that AdvaMed 2015 was “the place to be.” Attendees were drawn by the unique combination of partici- pants and presenters – including those from small, medium and large companies; local, national and international govern- ments; academia; and the financial community – that provided unmatched opportunities to gain insight, network and make business connections. Highlights included 35 world-class educational panels addressing key regulatory, reimbursement, compliance, legal, business and international issues, with special tracks focusing on in vitro diagnostics, emerging growth companies, finance, e-health and other areas. Through such popular and informative offerings as the CEOs Unplugged Series and Entrepreneurship Boot Camp, attendees had the opportunity to hear from and interact with some of the key movers and shakers in our diverse and dynamic industry. New to this year’s confer- ence, the Innovation Showcase featured presentations by 48 emerging growth compa- nies, giving attendees, potential investors and partners a compelling glimpse of the latest “THE PLACETO BE ” A D V A M E D 2 0 1 5 Michael Eisner, former chairman and CEO of the Walt Disney Company, speaks at a plenary lunch on creativity, innovation and the value of great partnerships. Janet Trunzo, AdvaMed senior executive vice president, technology and regulatory affairs (at left), moderates a CDRH Town Hall meeting with agency leaders, including (from left to right) CDRH Director Jeff Shuren; Bill MacFarland, director, Division of Enforcement B, Office of Compliance; Owen Faris, acting clinical trials director, Office of Device Evaluation; Tahseen Mirza, deputy director, policy and administration, Office of Surveillance and Biometrics; and Alberto Gutierrez, director, Office of In Vitro Diagnostics & Radiological Health. General Stanley McChrystal (retired) shares his insights on leadership, teamwork and geopolitical affairs with conference attendees, including John Kilcoyne, president and CEO of ReVision Optics (at right). A D V A M E D 2 0 1 5 A N N U A L R E P O R T